Expression and cellular localization of low-density lipoprotein receptor-related protein/α2-macroglobulin receptor in human glioblastoma in vivoreceptor in human glioblastoma in vivo
Abstract
Low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) has been proposed to mediate the cellular uptake and clearance of inactivated protease-inhibitor complexes in regulating proteinase activity at the cell surface, which is necessary for cellular migration and invasive processes. In this study, we investigated the presence of both LRP and urokinase-type plasminogen activator receptor (uPAR) in glioblastoma by reverse transcriptase-polymerase chain reaction (RT-PCR), and the cellular localization of LRP in glioblastoma tissues by immunohistochemical analysis. LRP mRNA was frequently expressed in glioblastomas and anaplastic astrocytomas compared with low-grade astrocytomas by RT-PCR analysis, and was well correlated with uPAR expression. The immunohistochemistry of LRP on sequential frozen sections showed that neoplastic glial cells and endothelial cells of glioblastomas exhibited intense LRP immunoreactivity, whereas LRP was almost undetectable in low-grade astrocytomas or in normal glial cells and endothelial cells of normal brain tissue. Glioblastomas from 11 patients in which the expression of LRP mRNA was observed by PCR displayed strong to moderate LRP immunoreactivity, with predominantly diffuse cytoplasmic and cell-surface localization. In normal brain tissues, LRP immunoreactivity was identified in the pyramidal neurons of the cerebral cortex. These results indicate that LRP is present both in the cellular cytoplasm and on the cell surface of glioblastomas with an increased expression of uPAR. Altered LRP expression might contribute to the stimulation of cell-surface proteolytic activity that in turn facilitates the invasiveness of glioblastoma in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LRP1 is highly expressed on glioma cells.
“Besides on the BBB, LRP1 was also found to be highly expressed on glioma cells39–41.”
From Brain-targeted drug delivery by manipulating protein corona functions (2019) · cites this paper as [40]
Cites
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler‐Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,701 · see citing works
The plasminogen activator/plasmin system.
Vassalli, J. D., Sappino, A. P., & Belin, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115405 · Cited by 1,179 · see citing works
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107 · see citing works
Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohlꝉ, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 955 · see citing works
The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 675 · see citing works
Strickland, D. K., Ashcom, J. D., Williams, S. E., Burgess, W. H., Migliorini, M. M., & Argraves, W. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38172-9 · Cited by 664 · see citing works
Herz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 611 · see citing works
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 602 · see citing works
Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V., & Brown, M. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5810 · Cited by 595 · see citing works
Nykjær, A., Petersen, C. M., Møller, B. K., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., & Andreasen, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42072-8 · Cited by 459 · see citing works
Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., & Saelinger, C. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42291-0 · Cited by 447 · see citing works
Blasi, F. (1993) · BioEssays · doi:10.1002/bies.950150206 · Cited by 400 · see citing works
Moestrup, S. K., Gliemann, J., & Pallesen, G. (1992) · Cell and Tissue Research · doi:10.1007/bf00353892 · Cited by 392 · see citing works
Cubellis, M. V., Wun, T.-C., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08213.x · Cited by 377 · see citing works
Bu, G., Williams, S. E., Strickland, D. K., & Schwartz, A. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7427 · Cited by 315 · see citing works
Bu, G., Geuze, H. J., Strous, G. J., & Schwartz, A. L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07221.x · Cited by 312 · see citing works
Directed Plasminogen Activation at the Surface of Normal and Malignant Cells
Pöllänen, J., Stephens, R. W., & Vaheri, A. I. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)61002-7 · Cited by 287 · see citing works
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.
Pepper, M. S., Vassalli, J. D., Montesano, R., & Orci, L. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.6.2535 · Cited by 280 · see citing works
Nielsen, L. S., Kellerman, G. M., Behrendt, N., Picone, R., Danø, K., & Blasi, F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69214-2 · Cited by 274 · see citing works
Yamamoto, M., Mohanam, S., Sawaya, R. A., Fuller, G. N., Seiki, M., Satō, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L., & Rao, J. S. (1996) · PubMed · Cited by 273 · see citing works
Self-citationOssowski, L. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2437 · Cited by 271 · see citing works
Orth, K., Madison, E. L., Gething, M.-J. H., Sambrook, J., & Herz, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7422 · Cited by 243 · see citing works
Striekland, D. K., Ashcom, J. D., Williams, S. E., Battey, F. D., Behre, E., Mctigue, K., Battey, J. F., & Argraves, W. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98848-4 · Cited by 229 · see citing works
LEUVEN, F. V., Cassiman, J. J., & BERGHE, H. V. D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50573-1 · Cited by 228 · see citing works
Bu, G., Maksymovitch, E. A., Nerbonne, J. M., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32340-2 · Cited by 216 · see citing works
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski, L., Clunie, G. J. A., Masucci, M. T., & Blasi, F. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.1107 · Cited by 206 · see citing works
Conese, M., Nykjær, A., Petersen, C. M., Cremona, O., Pardi, R., Andreasen, P. A., Gliemann, J., Christensen, E., & Blasi, F. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1609 · Cited by 191 · see citing works
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis, M. V., Andreasen, P. A., Ragno, P., Mayer, M., Danø, K., & Blasi, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4828 · Cited by 179 · see citing works
Wolf, B. B., Lopes, M. B. S., VandenBerg, S. R., & Gonias, S. L. (1992) · PubMed Central · Cited by 174 · see citing works
Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo.
Yamamoto, M., Sawaya, R. A., Mohanam, S., Bindal, A. K., Bruner, J. M., Oka, K., Rao, V. H., Tomonaga, M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 154 · see citing works
Self-citationExpression and localization of urokinase-type plasminogen activator receptor in human gliomas.
Yamamoto, M., Sawaya, R. A., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 149 · see citing works
Self-citationBu, G., Maksymovitch, E. A., Geuze, H. J., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43962-2 · Cited by 135 · see citing works
Heegaard, C. W., Simonsen, A. C. W., Oka, K., Kj, L., Christensen, A., Madsen, B. K., Ellgaard, L., Chan, L., & Andreasen, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20855 · Cited by 110 · see citing works
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H. J., & Tomonaga, M. (1997) · PubMed · Cited by 102 · see citing works
Self-citationNarita, M., Bu, G., Herz, J., & Schwartz, A. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118105 · Cited by 86 · see citing works
α2‐Macroglobulin and the α2‐Macroglobulin Receptor/LRP A Growth Regulatory Axisa
Gonias, S. L., LaMarre, J., Crookston, K. P., Webb, D. J., Wolf, B. B., Lopes, M. B. S., Moses, H. L., & HAYES, M. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44318.x · Cited by 77 · see citing works
LDL receptor-related protein (LRP): a multiligand receptor
Strickland, D. K., Kounnas, M. Z., Williams, S. E., & Argraves, W. S. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90718-8 · Cited by 62 · see citing works
Kancha, R. K., Stearns, M. E., & Hussain, M. M. (1994) · PubMed · Cited by 61 · see citing works
Blasi, F. (1993) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(93)90083-8 · Cited by 56 · see citing works
de Vries, T. J., Verheijen, J. H., de Bart, A. C. W., Weidle, U. H., Ruiter, D. J., & Gn, V. M. (1996) · PubMed · Cited by 48 · see citing works
Yamamoto, M., Sawaya, R. A., Mohanam, S., Loskutoff, D. J., Bruner, J. M., Rao, V. H., Oka, K., Tomonaga, M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 45 · see citing works
Self-citationDefinitions and Explanatory Notes
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Springer eBooks · doi:10.1007/978-3-642-84988-6_3 · Cited by 43 · see citing works
Proteolysis and invasiveness of brain tumors: Role of urokinase-type plasminogen activator receptor
Mohanam, S., Sawaya, R. A., Yamamoto, M., Bruner, J. M., Nicholson, G. L., & Rao, J. S. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052890 · Cited by 41 · see citing works
Self-citationLuna, M. C., Ferrario, A., Rucker, N., & Gomer, C. J. (1995) · PubMed · Cited by 37 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847 · see citing works
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · see citing works
Brain-targeted drug delivery by manipulating protein corona functions
Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334 · see citing works
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., Mikkelsen, T., Rosenfeld, S., Sarantopoulos, J., Meyers, C. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2481 · Cited by 190 · see citing works
Proteases and Glioma Angiogenesis
Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00118.x · Cited by 131 · see citing works
Uptake of lipoproteins for axonal growth of sympathetic neurons
Posse de Chaves, E. I., Vance, D. E., Campenot, R. B., Kiss, R. S., & Vance, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.26.19883 · Cited by 105 · see citing works
Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Boonstra, M. C., Verspaget, H. W., Ganesh, S., Kubben, F. J. G. M., Vahrmeijer, A. L., van de Velde, C. J. �., Kuppen, P. J. K., Quax, P. H. A., & Sier, C. F. M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796718233 · Cited by 98 · see citing works
Watson, M. A., Perry, A., Budhraja, V., Budhjara, V., Hicks, C., Shannon, W. D., & Rich, K. M. (2001) · PubMed · Cited by 80 · see citing works
Qiu, Z. J., Strickland, D. K., Hyman, B. T., & Rebeck, G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112066200 · Cited by 75 · see citing works
Zhang, Z., Xin, X., Liu, C., Liu, Y., Duan, H., Qi, L., Zhang, Y., Zhao, H., Chen, L., Jin, M., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01097-8 · Cited by 70 · see citing works
Peptide-Based Strategies for Targeted Tumor Treatment and Imaging
Ayo, A., & Laakkonen, P. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040481 · Cited by 64 · see citing works
Amos, S., Mut, M., diPierro, C. G., Carpenter, J. E., Xiao, A., Kohutek, Z. A., Redpath, G. T., Zhao, Y., Wang, J., Shaffrey, M. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0030 · Cited by 43 · see citing works
Kim, S. H., Adhikari, B. B., Cruz, S., Schramm, M. P., Vinson, J. A., & Narayanaswami, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135130 · Cited by 33 · see citing works
Bu, X., Khankaldyyan, V., Gonzales-Gomez, I., Groshen, S. G., Ye, W., Zhuo, S., Pons, J., Stratton, J., Rosenberg, S., & Laug, W. E. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700089 · Cited by 28 · see citing works
Zhang, H., Lee, J. M., Wang, Y., Li, D., Ko, K. W. S., Pelletier, L., & Yao, Z. (2007) · Biochemical Journal · doi:10.1042/bj20071127 · Cited by 25 · see citing works
Shruthi, N. R., Behera, M. M., Naik, S. K., Das, S. K., Gopan, S., Ghosh, A. K., Sahu, R. N., Patra, S., & Purkait, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1003730 · Cited by 20 · see citing works
Peptide-Based Vectors: A Biomolecular Engineering Strategy for Gene Delivery
Urandur, S., & Sullivan, M. O. (2023) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-101121-070232 · Cited by 18 · see citing works
Cancer and the blood–brain barrier: ‘Trojan horses’ for courses?
Mazza, M., Uchegbu, I. F., & Schätzlein, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.274 · Cited by 16 · see citing works
Role of proteins of the macroglobulin family in regulation of tumor growth
Na, Z., Зорина, В. Н., & Зорина, Р. М. (2006) · Russian Journal of Developmental Biology · doi:10.1134/s1062360406010024 · Cited by 14 · see citing works
The role of the plasminogen activation cascade in glioma cell invasion: a review
Tsatas, D., & Kaye, A. H. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(02)00328-4 · Cited by 13 · see citing works
Burke, S., Pratt, J., Beauchemin, D., Haïdara, K., & Annabi, B. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s38894 · Cited by 10 · see citing works
Lubitz, L. J., Haffner, M. P., Rieger, H., & Leneweit, G. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091112 · Cited by 6 · see citing works
Role and Regulation of Proteases in Human Glioma
Lakka, S. S., & Rao, J. S. (2006) · Springer eBooks · doi:10.1007/0-387-23101-3_7 · Cited by 3 · see citing works
Role of Urokinase-Type Plasminogen Activator Receptor in Human Glioma Invasion
Mohanam, S., & Rao, J. S. (2005) · Humana Press eBooks · doi:10.1385/1-59259-843-9:237
- Authors
- Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., & Tomonaga, M.
- Affiliations
- Fukuoka University (JP)
- Corresponding author
- Yamamoto, Masaaki
- ORCID
- Yamamoto, Masaaki
- Venue
- Brain Tumor Pathology
- Published
- 1998-03
- Volume
- 15
- Issue
- 1
- Pages
- 23-30
- ISSN
- 1433-7398 (ISSN-L)
- 1861-387X
- OpenAlex
- W213787128
- Cited by
- 25
- References
- 44
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Brain Tumor Pathology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fukuoka University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- low density lipoprotein receptor-related protein, alpha2-macroglobulin receptor, glioblastoma, urokinase-type plasminogen activator receptor, anaplastic astrocytoma, astrocytoma, protease-inhibitor complex, tumor invasion, endothelial cells, cortical neurons
- MeSH terms
- alpha-Macroglobulins, Brain, Brain Neoplasms, Glioblastoma, Humans, Immunohistochemistry, Neoplasm Invasiveness, Receptors, Cell Surface, Receptors, Immunologic, Receptors, LDL, RNA, Messenger, Urokinase-Type Plasminogen Activator, Reverse Transcriptase Polymerase Chain Reaction, Low Density Lipoprotein Receptor-Related Protein-1, Receptors, Urokinase Plasminogen Activator
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
